DexCom, Inc. provided earnings guidance for the year 2022. For the year 2022, the company expects revenue of approximately $2.88 billion to $2.91 billion (18-19% reported growth).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.8 USD | +0.32% | -6.74% | -4.28% |
05-30 | Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target | MT |
05-24 | Declaration of Voting Results by DexCom, Inc | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.28% | 47.24B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- DexCom, Inc. Provides Earnings Guidance for the Year 2022